Sylvain Lother, MD, FRCPC, DTMH

Research summary

Dr. Lother's program of research is focused on improving outcomes from life threatening infections. He co-leads a large, international, adaptive platform trial evaluating treatments that aim to prevent critical illness and improve outcomes for patients with pneumonia.

The three main pillars of Dr. Lother's research focus in pneumonia are:

1. Evaluating treatments that prevent critical illness and improve outcomes.
2. Collecting biological samples for evaluating microbiological and host factors that predict outcomes or treatment response.
3. Improving clinical trial methods by evaluating novel consent methods in trials.

Through Dr. Lother's work and achievements, he continues to contribute to a rapidly expanding understanding of COVID-19 and other pneumonia syndromes in Manitoba and internationally.

Keywords

• clinical trials
• consent methods
• COVID-19
• pneumonia

Brief bio

Dr. Lother is an assistant professor at the University of Manitoba, sections of Infectious Diseases and Critical Care. He is an early career clinician-investigator.

Education

Master of Science, Department of Community Health Sciences, University of Manitoba (Expected 2024)

Degree in Tropical Medicine and Hygiene, University of Alabama at Birmingham and Cayetano Heredia University (2018)

Doctor of Medicine, University of Manitoba (2013)

Bachelor of Science in Medicine, University of Manitoba (2011)

Bachelor of Science (Microbiology), University of Manitoba (2009)

Awards

Top 40 under 40 in Medicine - Doctors of Manitoba (2023)

Dr. Ethan Rubenstein Clinical Scientist Award (2021)

Diane Biehl Research Award (2020)

Hector Ma Award in Research (2019)

Joe Lee Award - Department of Critical Care and Anesthesia (2019)

Juan A. Embil Award for Excellence in Infectious Disease Research (2018)

CSCI/CIHR UBC Resident Research Prize Manuscript Award Winner (2017)